These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3946808)

  • 21. Effects of Ca2+ channel blockers on cortical hypoperfusion and expression of c-Fos-like immunoreactivity after cortical spreading depression in rats.
    Shimazawa M; Hara H; Watano T; Sukamoto T
    Br J Pharmacol; 1995 Aug; 115(8):1359-68. PubMed ID: 8564192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flunarizine, a calcium channel blocker: a new prophylactic drug in migraine.
    Amery WK
    Headache; 1983 Mar; 23(2):70-4. PubMed ID: 6343298
    [No Abstract]   [Full Text] [Related]  

  • 23. Flunarizine, a calcium channel blocker, in the prophylactic treatment of migraine.
    Diamond S; Schenbaum H
    Headache; 1983 Jan; 23(1):39-42. PubMed ID: 6826350
    [No Abstract]   [Full Text] [Related]  

  • 24. Relationship between regional calcium content and energy metabolism during recovery from prolonged cerebral ischemia.
    Grosse Ophoff B; Hossmann KA; Bodsch W; Paschen W
    Monogr Neural Sci; 1984; 11():22-7. PubMed ID: 6738553
    [No Abstract]   [Full Text] [Related]  

  • 25. Measurement of ischemic changes in cerebral blood flow by the hydrogen clearance technique and brain cortical temperature. Influence of flunarizine.
    Marrannes R; Edmonds HL; Wauquier A; Melis W; Van Loon J
    Arch Int Pharmacodyn Ther; 1986 Jun; 281(2):209-29. PubMed ID: 3753102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anticonvulsive properties of cinnarizine and flunarizine in rats and mice.
    Desmedt LK; Niemegeers CJ; Janssen PA
    Arzneimittelforschung; 1975 Sep; 25(9):1408-13. PubMed ID: 1242663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of nimodipine on cerebral functional and metabolic recovery following ischemia in the rat brain.
    Mabe H; Nagai H; Takagi T; Umemura S; Ohno M
    Stroke; 1986; 17(3):501-5. PubMed ID: 3715951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of calmodulin-dependent cyclic nucleotide phosphodiesterase by flunarizine, a calcium-entry blocker.
    Kubo K; Matsuda Y; Kase H; Yamada K
    Biochem Biophys Res Commun; 1984 Oct; 124(2):315-21. PubMed ID: 6093793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of calcium antagonists on postischemic protein biosynthesis in gerbil brain.
    Xie Y; Seo K; Ishimaru K; Hossmann KA
    Stroke; 1992 Jan; 23(1):87-92. PubMed ID: 1731425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inability of flunarizine, lidoflazine or magnesium to counteract delayed hypoperfusion after forebrain ischaemia in the rat.
    Grøgaard B; Gerdin B; Arfors KE
    Acta Neurochir (Wien); 1988; 95(3-4):136-42. PubMed ID: 3228003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of (E)-1-[bis (4-fluorophenyl)methyl]-4-(3-phenyl-2-propenyl) piperazine dihydrochloride(flunarizine) on cerebral circulation].
    Kubo K; Karasawa A; Yamada K; Nito M; Shuto K; Nakamizo N
    Nihon Yakurigaku Zasshi; 1982 May; 79(5):383-400. PubMed ID: 7129248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of Ca-antagonist (Flunarizine) on kindling seizures in suckling rats].
    Lee S; Kawawaki H; Matsuoka O; Murata R
    No To Hattatsu; 1986 Jul; 18(4):292-8. PubMed ID: 3730190
    [No Abstract]   [Full Text] [Related]  

  • 33. A trial of flunarizine in the treatment of Duchenne muscular dystrophy.
    Dick DJ; Gardner-Medwin D; Gates PG; Gibson M; Simpson JM; Walls TJ
    Muscle Nerve; 1986 May; 9(4):349-54. PubMed ID: 3520308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood flow to primary tumors and lymph node metastases in SMT-2A tumor-bearing rats following intravenous flunarizine.
    Kaelin WG; Shrivastav S; Jirtle RL
    Cancer Res; 1984 Mar; 44(3):896-9. PubMed ID: 6692410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Flunarizine in the treatment of arteriopathies of the legs].
    Catalano M; Sacchi E; Tomasini M; Coazzoli E; Parolini A; Dall'Oglio A; Libretti A
    Ric Clin Lab; 1985; 15 Suppl 1():475-8. PubMed ID: 4035228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Flunarizine, cerebral blood flow and reversion of experimental atherosclerosis in rabbit.
    Favalli L; Lanza E; Rozza Dionigi A; Assogna G; Goggi D; Ricevuti G
    Drugs Exp Clin Res; 1985; 11(12):845-50. PubMed ID: 3836114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Flunarizine, a calcium channel antagonist, is partially prophylactically neuroprotective in hypoxic-ischemic encephalopathy in the fetal sheep.
    Gunn AJ; Williams CE; Mallard EC; Tan WK; Gluckman PD
    Pediatr Res; 1994 Jun; 35(6):657-63. PubMed ID: 7936814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Migraine prevention by a calcium channel blocker. Results of a double-blind study of flunarizine vs. pizotifen].
    Wörz R; Drillisch C
    MMW Munch Med Wochenschr; 1983 Jul; 125(32-33):711-14. PubMed ID: 6415411
    [No Abstract]   [Full Text] [Related]  

  • 39. Neurological recovery after cardiac arrest: clinical feasibility trial of calcium blockers.
    Schwartz AC
    Am J Emerg Med; 1985 Jan; 3(1):1-10. PubMed ID: 3882095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Epilepsy: fewer attacks with flunarizine].
    Fortschr Med Suppl; 1985; 8():13-5. PubMed ID: 2867019
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.